Brand-name drug
Valtoco price, strengths & recalls
Brand of diazepam (generic)
Pharmacies pay $730.71 for 2 vials of Valtoco 10 mg dose kit pack this week, and from $730.71 to $1,461.66 across its 4 priced strengths and forms. The generic, diazepam, costs pharmacies from $0.63. It has 13 recalls on record, none ongoing. Its official label last changed on June 5, 2026.
Brand- Fair cash price
- $850.82
- Strengths
- 4
- Makers
- 1
- Updated
- Nov 11
Valtoco price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 5 mg dose kit pack Brand | $365.82 | $731.65 / 2 vials |
| 10 mg dose kit pack Brand | $365.36 | $730.71 / 2 vials |
| 15 mg dose kit pack Brand | $365.41 | $1,461.66 / 4 vials |
| 20 mg dose kit pack Brand | $365.37 | $1,461.49 / 4 vials |
Valtoco vs generic diazepam
GenericDiazepam pricesSupply status: shortages & recalls
Recalls
Showing the 6 most relevant of 13 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Valtoco
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use VALTOCO nasal spray safely and effectively. See full prescribing information for VALTOCO nasal spray. VALTOCO® (diazepam nasal spray), CIV Initial U.S. Approval: 1963
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS
Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs for patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation [see Warnings and Precautions (5.1) and Drug Interactions (7.1)].
The use of benzodiazepines, including VALTOCO, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Abuse and misuse of benzodiazepines commonly involve concomitant use of other medications, alcohol, and/or illicit substances, which is associated with an increased frequency of serious adverse outcomes. Before prescribing VALTOCO and throughout treatment, assess each patient's risk for abuse, misuse, and addiction [see Warnings and Precautions (5.2)].
The continued use of benzodiazepines may lead to clinically significant physical dependence. The risks of dependence and withdrawal increase with longer treatment duration and higher daily dose. Although VALTOCO is indicated only for intermittent use [see Indications and Usage (1) and Dosage and Administration (2)], if used more frequently than recommended, abrupt discontinuation or rapid dosage reduction of VALTOCO may precipitate acute withdrawal reactions, which can be life-threatening. For patients using VALTOCO more frequently than recommended, to reduce the risk of withdrawal reactions, use a gradual taper to discontinue VALTOCO [see Warnings and Precautions (5.3)].
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS
See full prescribing information for complete boxed warning
Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. (5.1, 7.1)
The use of benzodiazepines, including VALTOCO, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death. Before prescribing VALTOCO and throughout treatment, assess each patient's risk for abuse, misuse, and addiction. (5.2)
Although VALTOCO is indicated only for intermittent use (1, 2), if used more frequently than recommended, abrupt discontinuation or rapid dosage reduction of VALTOCO may precipitate acute withdrawal reactions, which can be life-threatening. For patients using VALTOCO more frequently than recommended, to reduce the risk of withdrawal reactions, use a gradual taper to discontinue VALTOCO. (5.3)
Recent major changes (as listed on the label)
Indications and Usage (1) | 04/2025 |
Dosage and Administration (2.2) | 04/2025 |
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA211635 · Neurelis Inc
- First approved
- January 10, 2020 (6 years ago)
- Latest approved change
- June 14, 2025
- Approved label
- PDF, Oct 27, 2025
- Generic makers
- 23 approved generic applications on the market
- Last patent listed
- June 10, 2042
- Exclusivity ends
- April 15, 2028
Valtoco questions
How much does valtoco cost without insurance?
Pharmacies pay about $730.71 for 2 vials of valtoco 10 mg dose kit pack ($365.36 per unit). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $850.82. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is there a generic for Valtoco?
Yes: diazepam. Pharmacies pay from $0.63 for it. Compare diazepam prices.
Is valtoco in shortage?
No shortage is reported for valtoco right now. We check the national shortage list every day.
Has valtoco been recalled?
13 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the valtoco label last change?
The official label was last updated on June 5, 2026 (version 15). See what changed.
Talk about valtoco
No comments yet. Questions, tips, what worked for you - start the conversation.